Agios Pharmaceuticals
Your dream job…could be 1 update away
Agios Pharmaceuticals Jobs and Salary Info
Find High Paying Jobs, Compensation Information and Expert Network Connections at Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for cancer and rare genetic diseases. The company's portfolio includes approved drugs for the treatment of acute myeloid leukemia and pyruvate kinase deficiency, as well as several investigational drugs in clinical and preclinical development. Agios was founded in 2008 and is headquartered in Cambridge, Massachusetts.
Snapshot
Employees390
IndustryPharmaceuticals & Biotech
Market Cap$1.5 billion
Revenue$203.2 million
5 Year Trend - http://www.bohemiancoding.com/sketch --%3e %3ctitle%3eicon_up_arrow%3c/title%3e %3cdesc%3eCreated with Sketch.%3c/desc%3e %3cdefs%3e%3c/defs%3e %3cg id='Latest' stroke='none' stroke-width='1' fill='none' fill-rule='evenodd'%3e %3cg id='Company---Member---D---Jobs-outside-of-role-Copy' transform='translate(-982.000000, -355.000000)' fill='%235DB200' fill-rule='nonzero'%3e %3cg id='Side-Rail' transform='translate(860.000000, 140.000000)'%3e %3cg id='Group' transform='translate(120.000000, 212.000000)'%3e %3cpath d='M5.07563983,5.56110462 C4.77203983,5.56110462 4.52590649,5.80723795 4.52590649,6.11097129 C4.52590649,6.41470462 4.77203983,6.66083795 5.07563983,6.66083795 L10.0627065,6.66083795 L2.22216017,14.5012509 C2.00749351,14.7160509 2.00749351,15.0641843 2.22216017,15.2787176 C2.32962684,15.3860509 2.47016017,15.4397843 2.61082684,15.4397843 C2.75162684,15.4397843 2.89216017,15.3860509 2.99962684,15.2787176 L10.8401732,7.43817129 L10.8401732,12.4253713 C10.8401732,12.7289713 11.0864398,12.9751046 11.3900398,12.9751046 C11.6935065,12.9751046 11.9397732,12.7289713 11.9397732,12.4253713 L11.9397732,5.56110462 L5.07563983,5.56110462 Z' id='icon_up_arrow' transform='translate(7.000467, 10.500444) rotate(-45.000000) translate(-7.000467, -10.500444) '%3e%3c/path%3e %3c/g%3e %3c/g%3e %3c/g%3e %3c/g%3e %3c/svg%3e)
+28%
+28%Net Income-$327.3 million
NASDAQAGIO
Founded2008
 - http://www.bohemiancoding.com/sketch --%3e %3ctitle%3eicon_annual_report%3c/title%3e %3cdesc%3eCreated with Sketch.%3c/desc%3e %3cdefs%3e%3c/defs%3e %3cg id='Latest' stroke='none' stroke-width='1' fill='none' fill-rule='evenodd'%3e %3cg id='Company---Member---D---Jobs-outside-of-role-Copy' transform='translate(-882.000000, -502.000000)' stroke='%233FB2BB'%3e %3cg id='Side-Rail' transform='translate(860.000000, 140.000000)'%3e %3cg id='SEC' transform='translate(22.000000, 362.000000)'%3e %3cg id='icon_annual_report'%3e %3ccircle id='Oval' cx='7.5' cy='9.5' r='7'%3e%3c/circle%3e %3cpath d='M15.738369,10.6580038 C16.0036733,9.87235759 16.1409201,9.04340379 16.1409201,8.1947821 C16.1409201,3.94507129 12.6958488,0.5 8.44613802,0.5 C8.12780349,0.5 7.81204007,0.519303384 7.5,0.557537525 L7.5,8.45053948 L15.738369,10.6580038 Z' id='Combined-Shape' fill='%23FFFFFF'%3e%3c/path%3e %3c/g%3e %3c/g%3e %3c/g%3e %3c/g%3e %3c/g%3e %3c/svg%3e)
Annual Report
'%3e %3ccircle cx='6.022' cy='6.636' r='5.73' fill='%23FFF' stroke='%2309AEBC'/%3e %3cpath fill='%2309AEBC' fill-rule='nonzero' d='M4.097 5.328l-.003.181a.321.321 0 0 0-.025.096c.035.515.279.914.726 1.15.34.181.714.295 1.073.44.239.095.491.168.712.295a.456.456 0 0 1 .011.78.832.832 0 0 1-.388.129c-.563.033-1.047-.181-1.474-.535-.074-.06-.131-.087-.2 0-.175.217-.35.435-.53.65-.071.085-.05.152.023.219.407.373.904.63 1.442.746.103.022.13.06.128.159-.005.22 0 .441 0 .663 0 .16.011.173.169.174h.623a.104.104 0 0 0 .09-.03.106.106 0 0 0 .03-.09c0-.246.003-.491 0-.736 0-.082.015-.12.11-.136.346-.057.668-.214.927-.452.368-.336.514-.775.547-1.26.006-.088-.036-.18-.056-.271l-.004-.06a.897.897 0 0 0-.016-.162 1.218 1.218 0 0 0-.658-.779c-.362-.172-.745-.302-1.117-.449-.235-.093-.474-.186-.7-.297a.396.396 0 0 1-.23-.422.399.399 0 0 1 .32-.357c.18-.038.363-.049.545-.03.353.035.664.198.957.392.094.06.151.046.215-.033.154-.196.312-.389.467-.585.127-.16.124-.177-.045-.294-.33-.228-.678-.417-1.077-.5-.19-.039-.188-.046-.188-.236v-.483a.84.84 0 0 0-.028-.14v-.182c.018-.086-.037-.088-.097-.087H5.75c-.114 0-.162.048-.16.162.002.215 0 .431 0 .647 0 .215 0 .219-.205.266-.359.083-.674.242-.917.522-.232.264-.392.566-.37.935z'/%3e %3c/g%3e %3cpath d='M-4.305-5.5h40v40h-40z'/%3e %3c/g%3e %3c/svg%3e)
'%3e %3cpath stroke='%236EA7E7' stroke-linecap='round' stroke-linejoin='round' d='M11.156 16.891C3.743 20.036.036 22.357.036 23.854v6.63h15.567'/%3e %3cpath stroke='%236EA7E7' stroke-linecap='round' d='M19.041 18.217l-2.72-1.326'/%3e %3cpath stroke='%2309AEBC' d='M13.52.032a5.52 5.52 0 0 1 5.525 5.527c0 1.528-.645 3.834-1.687 5.699-1.042 1.865-2.457 3.228-3.839 3.228-1.382 0-2.797-1.363-3.84-3.228-1.041-1.865-1.686-4.17-1.686-5.7A5.52 5.52 0 0 1 13.519.033z'/%3e %3cpath stroke='%23666' stroke-linejoin='round' d='M13.139 16.916c.194.04 1.005.04 1.2 0l1.851 8.47-2.451 2.273-2.452-2.273 1.852-8.47z'/%3e %3cpath stroke='%23FB8648' stroke-linejoin='round' stroke-width='.8' d='M24 28.014l-2.59 1.773.887-3.01-2.487-1.914 3.138-.087 1.051-2.956 1.051 2.956 3.138.087-2.487 1.914.887 3.01z'/%3e %3ccircle cx='23.999' cy='26.224' r='7.607' stroke='%23FB8648'/%3e %3c/g%3e %3c/g%3e %3c/svg%3e)
